UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6676
Citius Oncology
CTOR
$53.9M
| $218K | ﹤0.01% |
334,619
+297,779
| +808% | +$237K |
2024 Q3
7 quarters
|
|
6677
Innovator Growth-100 Dual Directional 5 Buffer ETF - Quarterly
DDNQ
$20.4M
| $216K | ﹤0.01% |
10,434
+10,429
| +208,580% | +$213K |
2026 Q1
1 quarter
|
|
6678
Rich Sparkle Holdings
ANPA
$18M
| $216K | ﹤0.01% |
50,173
+5,526
| +12% | +$36.7K |
2025 Q3
3 quarters
|
|
6679
Dimensional Core Fixed Income ETF
DFCF
$11.7B
| $215K | ﹤0.01% |
5,103
+3,382
| +197% | +$143K |
2026 Q1
1 quarter
|
|
6680
CALL
Insmed
INSM
$25.1B
| $215K | ﹤0.01% |
+2,016
| New | +$244K |
2026 Q2
0 quarters
|
|
6681
RF Industries
RFIL
$72.2M
| $214K | ﹤0.01% |
10,112
-4,588
| -31% | -$74.2K |
2025 Q1
5 quarters
|
|
6682
Chemung Financial Corp
CHMG
$409M
| $214K | ﹤0.01% |
2,872
+770
| +37% | +$51.6K |
2017 Q3
35 quarters
|
|
6683
Zone Frontier Inc.
ZONE
$26.2M
| $214K | ﹤0.01% |
4,351
+4,344
| +62,057% | +$145K |
2025 Q4
2 quarters
|
|
6684
Radiant Logistics
RLGT
$418M
| $214K | ﹤0.01% |
22,621
+7,424
| +49% | +$62.6K |
2022 Q4
14 quarters
|
|
6685
Vox Royalty Corp
VOXR
$342M
| $214K | ﹤0.01% |
45,241
-39,551
| -47% | -$218K |
2024 Q4
6 quarters
|
|
6686
Highland Opportunities and Income Fund
HFRO
$333M
| $213K | ﹤0.01% |
29,943
+11,295
| +61% | +$72.5K |
2017 Q4
34 quarters
|
|
6687
CALL
Klaviyo
KVYO
$5.83B
| $213K | ﹤0.01% |
+14,112
| New | +$234K |
2026 Q2
0 quarters
|
|
6688
Organigram Holdings
OGI
$126M
| $213K | ﹤0.01% |
208,770
+176,155
| +540% | +$215K |
2019 Q2
28 quarters
|
|
6689
Blue Moon Metals Inc
BMM
$341M
| $213K | ﹤0.01% |
33,275
-1,049
| -3% | -$7.45K |
2026 Q1
1 quarter
|
|
6690
SS Innovations International
SSII
$423M
| $213K | ﹤0.01% |
51,208
-104,333
| -67% | -$424K |
2025 Q2
4 quarters
|
|
6691
AleAnna Inc
ANNA
$83.5M
| $211K | ﹤0.01% |
72,921
+63,641
| +686% | +$244K |
2025 Q1
5 quarters
|
|
6692
Rocket One Inc
RKTO
$10M
| $211K | ﹤0.01% |
211,304
+53,327
| +34% | +$49K |
2022 Q1
17 quarters
|
|
6693
Direxion Daily S&P 500 High Beta Bull 3X ETF
HIBL
$60.5M
| $211K | ﹤0.01% |
1,606
+1,605
| +160,500% | +$163K |
2023 Q3
11 quarters
|
|
6694
Matthews China Active ETF
MCH
$14.9M
| $211K | ﹤0.01% |
7,321
| – | – |
2022 Q4
14 quarters
|
|
6695
Tvardi Therapeutics
TVRD
$12.8M
| $211K | ﹤0.01% |
111,133
+60,679
| +120% | +$190K |
2014 Q4
46 quarters
|
|
6696
Credit Suisse X-Links Silver Shares Covered Call ETNs due April 21 2033
SLVO
$9.9M
| $210K | ﹤0.01% |
3,232
+3,118
| +2,735% | +$262K |
2025 Q4
2 quarters
|
|
6697
JPMorgan ActiveBuilders Emerging Markets Equity ETF
JEMA
$1.55B
| $210K | ﹤0.01% |
3,291
+2,106
| +178% | +$127K |
2025 Q3
3 quarters
|
|
6698
ChronoScale Holdings
CHRN
$1.57B
| $210K | ﹤0.01% |
9,457
+8,433
| +824% | +$130K |
2016 Q3
39 quarters
|
|
6699
BNY Mellon Global Infrastructure Income ETF
BKGI
$1.96B
| $210K | ﹤0.01% |
4,663
| – | – |
2025 Q2
4 quarters
|
|
6700
EQV Ventures Acquisition Corp II
EVAC
$606M
| $210K | ﹤0.01% |
20,589
+19,809
| +2,540% | +$201K |
2025 Q4
2 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,282 new, 4,216 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,282 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.